These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25773358)

  • 1. Introduction of a nomogram for predicting adverse pregnancy outcomes based on maternal serum markers in the quad screen test.
    An JJ; Ji HY; You JY; Woo SY; Choi SJ; Oh SY; Roh CR; Kim JH
    Arch Gynecol Obstet; 2015 Sep; 292(3):589-94. PubMed ID: 25773358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of quad serum markers for adverse pregnancy outcome in antiphospholipid antibody syndrome.
    Hong SY; Kim SY; Kim JH; Hong JY; Sung JH; Choi SJ; Oh SY; Roh CR
    Lupus; 2021 May; 30(6):981-990. PubMed ID: 33709835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review.
    Hui D; Okun N; Murphy K; Kingdom J; Uleryk E; Shah PS
    J Obstet Gynaecol Can; 2012 Feb; 34(2):142-153. PubMed ID: 22340063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is maternal serum inhibin A a good predictor in preterm labor? - Experience from a community hospital in Taiwan.
    Huang SY; Wang YC; Yin WC; Teng LF; Huang YC; Wu YL; Lo TS
    Biomed J; 2020 Apr; 43(2):183-188. PubMed ID: 32387268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of preeclampsia using inhibin a and other second-trimester serum markers.
    Ree PH; Hahn WB; Chang SW; Jung SH; Kang JH; Cha DH; Kang MS; Huh JY
    Fetal Diagn Ther; 2011; 29(4):280-6. PubMed ID: 21252475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
    Gu W; Lin J; Hou Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population.
    Lao MR; Calhoun BC; Bracero LA; Wang Y; Seybold DJ; Broce M; Hatjis CG
    J Med Screen; 2009; 16(2):55-9. PubMed ID: 19564516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
    Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
    Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
    Hu J; Zhang J; He G; Zhu S; Tang X; Su J; Li Q; Kong Y; Zhu B
    BMC Pregnancy Childbirth; 2020 Feb; 20(1):104. PubMed ID: 32050927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
    Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
    Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-marker screening in human immunodeficiency virus-positive pregnant women: Screen positivity rates with the triple and quad screens.
    Yudin MH; Prosen TL; Landers DV
    Am J Obstet Gynecol; 2003 Oct; 189(4):973-6. PubMed ID: 14586337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal analyte preeclampsia: do the second-trimester maternal serum analytes help differentiate preeclampsia subtypes?
    Critchfield AS; Paulus JK; Farez R; Urato AC
    J Perinatol; 2013 Oct; 33(10):754-8. PubMed ID: 23702620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
    Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated low second-trimester maternal serum beta-human chorionic gonadotropin is not associated with adverse pregnancy outcome.
    Endres LK; Krotz S; Grobman WA
    Am J Obstet Gynecol; 2003 Sep; 189(3):755-7. PubMed ID: 14526308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of combined serum biomarkers for adverse pregnancy outcomes.
    Cohen JL; Smilen KE; Bianco AT; Moshier EL; Ferrara LA; Stone JL
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():89-94. PubMed ID: 25129153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.